CORC

在结果中检索

CORC

浏览/检索结果: 共439条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer 期刊论文
2019, 卷号: 54, 期号: 9, 页码: 588-594
作者:  Wang Y T;  Li B;  Li X G;  Ma S K;  Zhang R
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer 会议论文
CANCER RESEARCH, 2019-02-01
作者:  Zhu, A.;  Yuan, P.;  Wang, J.;  Fan, Y.;  Luo, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer 期刊论文
2019, 卷号: 79, 期号: 4
作者:  Zhu, A.;  Yuan, P.;  Wang, J.;  Fan, Y.;  Luo, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical model 期刊论文
2019, 卷号: 18, 期号: 2, 页码: 2091-2101
作者:  Gu, Junjie;  Li, Zhe;  Zhou, Jianfeng;  Sun, Zhao;  Bai, Chunmei
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
REAL WORLD TREATMENT PATTERNS ANALYSIS FOR PATIENTS WITH ADVANCED OR METASTATIC LUNG CANCER IN THEIR INITIAL TREATMENT: A NATIONWIDE, MULTI-CENTER, RETROSPECTIVE MEDICAL CHART REVIEW IN CHINA (PASSION STUDY) 期刊论文
2019, 卷号: 22, 页码: S95-S95
作者:  Qiu, B.;  Fan, L.;  Tang, Z.;  He, J.;  Wang, P. F.
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 会议论文
ANNALS OF ONCOLOGY, 2019-04-01
作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 期刊论文
2019, 卷号: 30, 页码: 67-67
作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A.
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer 期刊论文
2019, 卷号: 11, 页码: 7707-7719
作者:  Liang, Hongge;  Wang, Mengzhao
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:  Zhou, Ming;  Chen, Xiaoyuan;  Zhang, Hong;  Xia, Lin;  Tong, Xin
收藏  |  浏览/下载：29/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace